Education News and Research

RSS

Medicaid spending claims increasingly larger share of state budgets

According to the National Association of State Budget Officers, Medicaid spending by the states has steadily gone up during the last three years, and this trend is likely to continue. Media outlets also report on Medicaid developments in Texas, Florida, New York and California.

15 Dec 2011

UT MD Anderson offers CAP gift for pediatric cancer patients

The holidays are here, and The University of Texas MD Anderson Cancer Center Children's Art Project (CAP), offers a line of gifts based on artwork created by pediatric cancer patients. Sale proceeds from each item fund a variety of educational and recreational programs for patients and their families.

15 Dec 2011

Cereblon protein now holds hope in fight against multiple myeloma

Research on the same protein that was a primary mediator of the birth defects caused by thalidomide now holds hope in the battle against multiple myeloma, say Mayo Clinic researchers who presented results of several clinical trials at the 53nd annual meeting of the American Society of Hematology Dec. 10-13 in San Diego.

15 Dec 2011

Chevron's role in fight against HIV/AIDS in Africa

In this Africa.com opinion piece, Ana Ruth Luis, medical director of the Southern Africa Strategic Business Unit at Chevron Africa and Latin America Ex in Angola, discusses what she calls "the important role Chevron has in driving down the incidence of HIV/AIDS in Africa."

15 Dec 2011

Vaginal progesterone reduces rate of preterm birth and neonatal complications

A team of investigators of the National Institutes of Health housed at the Detroit Medical Center (DMC) and Wayne State University (WSU) published today that performing a cervical ultrasound in all pregnant women and treating those with a short cervix with vaginal progesterone reduces the rate of preterm birth and neonatal complications.

15 Dec 2011

Mayo Clinic to build new cancer treatment facility

Mayo Clinic broke ground today for a cutting edge cancer therapy facility at its Phoenix campus. Construction begins this month on a $182 million facility to house Mayo Clinic's Proton Beam Therapy program - marking the beginning of a new era in cancer treatment.

15 Dec 2011

First Total Artificial Heart implant performed at NewYork-Presbyterian/Columbia

Surgeons at NewYork-Presbyterian Hospital/Columbia University Medical Center performed the first Total Artificial Heart implant in the New York City area to replace a patient's dying heart.

15 Dec 2011

ACR's Radiology Leadership Institute, RBMA form partnership

The Radiology Business Management Association (RBMA) is the first affiliate organization of the American College of Radiology's Radiology Leadership Institute (RLI). This is the latest step in the development of the RLI — radiology's first professional development and leadership academy — set to launch in July 2012.

15 Dec 2011

MDC professor to receive Gottfried Wilhelm Leibniz Prize

Professor Nikolaus Rajewsky of the Max Delbr-ck Center for Molecular Medicine (MDC) Berlin is to receive Germany's most prestigious research award, the Gottfried Wilhelm Leibniz Prize.

15 Dec 2011

Scientists evaluate toxicity of Peruvian plant species in traditional medicine

Many developing countries rely on traditional medicine as an accessible and affordable treatment option for human maladies. However, until now, scientific data has not existed to evaluate the potential toxicity of medicinal plant species in Peru. Scientists from the William L. Brown Center of the Missouri Botanical Garden in St. Louis led a study using brine shrimp to determine the toxicity of 341 Northern Peruvian plant species commonly ingested in traditional medicine.

15 Dec 2011

Fast Forward, Lineagen to fund clinical development and validation of blood-based assay for MS

Lineagen, Inc., an innovative molecular diagnostics company focused on complex, genetically linked disorders, and Fast Forward, LLC, a nonprofit subsidiary of the National Multiple Sclerosis Society, today announced an alliance to fund the clinical development and validation of a blood-based assay for multiple sclerosis.

15 Dec 2011

National conference on mindfulness for children

Beginning February 4, 2012, the UC San Diego Center for Mindfulness will host a national conference for teachers, parents, therapists, and school administrators called Bridging the Hearts & Minds of Youth. The two-day conference is designed to familiarize and train attendees with the ways in which mindfulness is being taught to children and teens in a variety of settings.

15 Dec 2011

Novel prognostic model for patients with treatment-related MDS

A large-scale analysis of patients whose myelodysplastic syndrome is related to earlier cancer treatment overturns the notion that all of them have a poor prognosis, researchers from The University of Texas MD Anderson Cancer Center report at the 53rd Annual Meeting of the American Society of Hematology.

15 Dec 2011

Roundup: Nonprofits get big money in disabled payments; Calif. budget problems bring additional Medicaid cutbacks

Spending on this little-known home care program, called Community Habilitation, has soared in recent years, creating multimillion-dollar surpluses at some nonprofit agencies and eye-popping salaries and benefits for those who run them. And it helps explain how New York's costs of caring for developmentally disabled people have ballooned in recent years, creating the nation's most generous system of Medicaid-financed programs, with little scrutiny of its efficiency or result.

15 Dec 2011

Dendrimers offers a new way to treat age-related macular degeneration, retinitis pigmentosa

Hitching a ride into the retina on nanoparticles called dendrimers offers a new way to treat age-related macular degeneration and retinitis pigmentosa. A study by investigators at Mayo Clinic, Wayne State University and Johns Hopkins Medicine shows that steroids attached to the dendrimers target the damage-causing cells associated with neuroinflammation, leaving the rest of the eye unaffected and preserving vision.

14 Dec 2011

Initiative for Women with Disabilities opens new facility in Manhattan

The Initiative for Women with Disabilities Elly and Steve Hammerman Health & Wellness Center (IWD) at NYU Langone Medical Center opened the doors to a new 4,200-square-foot facility located at 359 Second Avenue in Manhattan.

14 Dec 2011

Angioplasties can be safely performed at centers that do not have on-site surgical capability

Contrary to current guidelines, Mayo Clinic researchers have found that elective or primary (in patients who have had heart attacks) angioplasties performed at centers without on-site cardiac surgery capabilities pose no increased risk for patient death or emergency bypass surgery.

14 Dec 2011

H2S plays critical role in signaling pathway linked to Alzheimer's and Parkinson's

Something rotten never smelled so sweet. This is what members of a team of scientists at Cold Spring Harbor Laboratory (CSHL) are telling one another as they discuss a new finding they did not expect to make. They have discovered that hydrogen sulfide (H2S) - the flammable, highly toxic gas that we usually associate with the smell of rotten eggs in landfills and sewers - plays an important role in the regulation of a signaling pathway implicated in biological malfunctions linked to Alzheimer's and Parkinson's diseases, among others.

14 Dec 2011

Potential nanoparticle treatment for macular degeneration and retinitis pigmentosa

Hitching a ride into the retina on nanoparticles called dendrimers offers a new way to treat age-related macular degeneration and retinitis pigmentosa. A collaborative research study among investigators at Wayne State University, the Mayo Clinic and Johns Hopkins Medicine shows that steroids attached to the dendrimers targeted the damage-causing cells associated with neuroinflammation, leaving the rest of the eye unaffected and preserving vision.

14 Dec 2011

Positive data from Nektar's NKTR-181 Phase 1 clinical study for chronic pain

Nektar Therapeutics today announced positive data from a Phase 1 clinical study of NKTR-181 evaluating multiple ascending oral doses of NKTR-181 over an 8-day treatment period in healthy subjects.

14 Dec 2011